温阳益气膏贴敷脐环对改善老年功能性便秘症状的疗效研究

目的 探讨温阳益气药贴敷脐环治疗老年功能性便秘症状的临床疗效及安全性.方法 将69例老年便秘患者随机分为观察组和对照组.观察组采用温阳益气药膏贴敷脐环,对照组采用大黄药膏贴敷神阙,2组均连续贴敷2周,分别于贴敷前及贴敷2周后收集平均每周自发完全排便次数(SCBM)、便秘临床症状积分、便秘患者症状自评量表(PAC-SYM)评分及贴敷期间不良反应.结果 2组贴敷2周后与贴敷前相比,SCBM明显增加、便秘临床症状得分及PAC-SYM评分显著降低(均P<0.05);贴敷2周后观察组上述3项疗效指标均优于对照组(P<0.05);贴敷期间2组均未发生不良反应.结论 温阳益气药贴敷脐环对增加老年功能性便秘患者的排便次数及改善便秘症状疗效更好,且用药安全,无不良反应.     

穴位贴敷治疗肝硬化腹水疗效的观察及护理

目的验证穴位贴敷治疗肝硬化腹水的安全性、有效性.方法将58例患者随机分为治疗组(30例)、对照组(28例).治疗组用穴位贴敷(以白芥子、延胡索、甘遂、细辛、肉桂等研细用凡士林调成糊状,做成直径约1厘米的药饼敷于穴上),同时根据证型内服中药汤剂;对照组单服中药汤剂.结果治疗组总有效率86.67%,对照组总有效率57.14%,治疗组优于对照组(P<0.05).结论中药穴位贴敷治疗肝硬化腹水具有确切的疗效.     

中药腹部贴敷治疗小儿便秘的疗效观察

目的：观察中药腹部贴敷治疗小儿便秘的疗效,并比较口服小儿太极丸有效性。方法将84例患儿随机分成两组,其中治疗组(44例)、对照组(40例)。治疗组用中药腹部贴敷(以三棱、莪术、大黄、芒硝、冰片打成粉与大葱汁搅成糊状,制成6 cm 为直径药饼,以肚脐为中心贴敷于腹部);对照组小儿太极丸口服。结果总有效率：治疗组81.8%,对照组50.0%,治疗组优于对照组(P<0.05);首次排便时间：治疗组(5.2±2.7) h,对照组(10.2±7.7) h,治疗组优于对照组(P<0.05)。结论治疗小儿便秘的中药腹部贴敷疗法,具有确切的疗效,适宜推广应用。     

中药穴位贴敷佐治毛细支气管炎的疗效观察和护理

[目的]探讨中药穴位贴敷佐治毛细支气管炎的临床疗效.[方法]将85例毛细支气管炎患儿随机分成对照组和观察组,对照组常规给西药治疗,观察组在对照组的基础上加用中药穴位贴敷治疗,每天一次,每贴12小时,5天为一疗程.两组均以临床症状体症的缓解为疗效标准.观察两组的治疗效果.采用SPSS10.0统计软件进行处理,两组间用x2检验.[结果]观察组优于对照组,两组经统计学处理,P＜0.05,差异有统计学意义.[结论]中药穴位贴敷佐治毛细支气管炎,疗效确切,无副作用,顺应性好,值得在儿科临床广泛实践.     

中药贴敷治疗毛细支气管炎的效果观察与护理

目的探讨中药贴敷治疗毛细支气管炎的临床效果。方法将180例诊断为毛细支气管炎的患儿分为两组,对照组常规治疗,观察组加用中药贴敷治疗,两组均以临床症状体征的缓解为疗效标准,观察两组的治疗效果。结果观察组总有效率优于对照组,两组比较差异有显著性(P<0.05)。结论中药贴敷联合西医治疗毛细支气管炎效果显著,无不良反应,值得在儿科临床推广应用。     

葫芦灸联合中药贴敷在寒湿凝滞证盆腔炎性疾病后遗症患者中的应用效果

目的：探讨葫芦灸联合中药贴敷在寒湿凝滞证盆腔炎性疾病后遗症患者中的应用效果。方法：选取2019年2月—2020年2月山东中医药大学附属医院收治的70例盆腔炎性疾病后遗症患者作为研究对象，以随机数字表法分为对照组与观察组，各35例。对照组实施艾灸联合中药贴敷治疗，观察组实施葫芦灸联合中药贴敷治疗。比较两组治疗效果及疼痛缓解情况。结果：观察组治疗总有效率高于对照组，差异有统计学意义(P<0.001)。两组疼痛缓解率比较，差异无统计学意义(P>0.05)。结论：葫芦灸联合中药贴敷对寒湿凝滞证盆腔炎性疾病后遗症患者的治疗效果显著，且操作简便，值得临床应用并予以推广。     

夏季穴位敷贴治疗小儿哮喘50例观察

笔者根据中医“缓则治本、冬病夏治”的原理，对50例小儿哮喘患者夏季应用中药穴位敷贴治疗，效果确切。一、病例资料50例患儿均为门诊病人，男27例，女23例；年龄3－12岁，平均672岁，其中支气管哮喘15例，喘息性支气管炎35例。病程最短6个月，最长12年。二、治疗方法1．穴位选择：背部两侧百劳、肺俞、膏盲穴。2．外敷药物：选用中药白芥子309、延胡索309、细辛15g、甘遂15g，共研细末。用新鲜生姜汁调成药饼6只，加人少许蜂蜜，药饼中心放置蜃香或丁香，3敷贴方法：将药饼用胶布固定敷于m应穴位L，每次贴敷Ill，一星期贴敷2次，一个月为…     

门诊中药贴敷治疗小儿秋季腹泻疗效观察

目的观察使用门诊中药贴敷对小儿秋季腹泻患儿实施治疗的临床效果。方法选取2013年11月至2016年11月在我院门诊接受治疗小儿秋季腹泻患儿80例作为本次研究对象,按照门诊顺序分成观察组与对照组,每组病人40例,对照组病人通过使用思密达妈咪爱实施治疗,观察组病人通过使用中药敷脐进行治疗,比较治疗组与对照组病人临床效果以及平均止泻时间。结果观察组病人治疗有效率达到%,优于对照组的%,差异有统计学意义,P0.05,另外在止泻时间方面观察也要优于对照组,差异有统计学意义,P0.05。结论使用门诊中药贴敷对小儿秋季腹泻患儿实施治疗的临床效果显著,可以推广。     

中药敷脐治疗慢性细菌性痢疾36例

目的:观察中药敷脐治疗慢性细菌性痢疾的临床疗效。方法:将 68例患者随机分成 2组,治疗组 36例,用中药敷脐治疗;对照组 32例,予氟哌酸、复方新诺明联合治疗。14d为 1个疗程,疗程间隔 4d,观察 2个疗程,分别判断其疗效及各组中病程与疗效的关系。结果:治疗组有效率 83. 3%,优于对照组 62. 5% (P<0. 05);治疗组中病程长短与疗效无相关性,对照组中呈负相关性。结论:中药敷脐治疗慢性细菌性痢疾,疗效满意,且患者病程越长,应用敷脐法越显得必要。     

艾灸加药贴治疗小儿虚寒型泄泻209例临床观察

目的 观察艾灸法配合药饼贴脐治疗小儿虚寒型泄泻的效果.方法 对418例虚寒型泄泻患儿随机分为二组,采用西医常规治疗为观察组,采用西医常规加艾灸法配合生姜附子药饼贴脐为治疗组,对二种治疗效果进行对比.结果 西药常规治疗组治愈率39.2%,治疗组治愈率达84.2%(P<0.05).结论 艾灸法配合生姜附子药饼贴脐治疗小儿虚寒型泄泻疗效显著,是一种安全、简便、经济、快速有效的方法,值得推广.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…